James S.H. Wong

478 total citations
26 papers, 178 citations indexed

About

James S.H. Wong is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Toxicology. According to data from OpenAlex, James S.H. Wong has authored 26 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 13 papers in Anesthesiology and Pain Medicine and 6 papers in Toxicology. Recurrent topics in James S.H. Wong's work include Opioid Use Disorder Treatment (20 papers), Pain Management and Opioid Use (12 papers) and Forensic Toxicology and Drug Analysis (6 papers). James S.H. Wong is often cited by papers focused on Opioid Use Disorder Treatment (20 papers), Pain Management and Opioid Use (12 papers) and Forensic Toxicology and Drug Analysis (6 papers). James S.H. Wong collaborates with scholars based in Canada, United States and Switzerland. James S.H. Wong's co-authors include Pouya Azar, Kerry L. Jang, Mohammadali Nikoo, Jean N. Westenberg, Michael Krausz, Nickie Mathew, Michael Krausz, Christian G. Schütz, Marc Vogel and Ehsan Moazen‐Zadeh and has published in prestigious journals such as Personality and Individual Differences, Addiction and Journal of Medical Internet Research.

In The Last Decade

James S.H. Wong

24 papers receiving 177 citations

Peers

Countries citing papers authored by James S.H. Wong

Since Specialization

Citations

This map shows the geographic impact of James S.H. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S.H. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S.H. Wong more than expected).

Fields of papers citing papers by James S.H. Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S.H. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S.H. Wong. The network helps show where James S.H. Wong may publish in the future.

Co-authorship network of co-authors of James S.H. Wong

This figure shows the co-authorship network connecting the top 25 collaborators of James S.H. Wong. A scholar is included among the top collaborators of James S.H. Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James S.H. Wong. James S.H. Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research 2025 ·Addiction ·James S.H. Wong, Anthony Lau, Pouya Azar	0
2	Case series: Symptom‐inhibited fentanyl induction (SIFI) onto treatment‐dose opioid agonist therapy in a community setting 2025 ·American Journal on Addictions ·Pouya Azar, Jane J. Kim, Richard Davison, (unknown), (unknown), James S.H. Wong, (unknown), (unknown), Michael Krausz, Nickie Mathew, Andrew A. Herring, (unknown)	0
3	Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report 2025 ·Addiction Science & Clinical Practice ·Pouya Azar, (unknown), Jin‐Tae Kim, James S.H. Wong, Mohammadali Nikoo, (unknown)	1
4	Direct Induction of Buprenorphine Extended-Release: A Case Report 2024 ·Journal of Addiction Medicine ·Pouya Azar, James S.H. Wong, (unknown), Mohammadali Nikoo, (unknown), (unknown), Nickie Mathew, Michael Krausz, Andrew A. Herring, (unknown), Julio Montaner, Anil R. Maharaj	1
5	Systematic review on intentional non-medical fentanyl use among people who use drugs 2024 ·Frontiers in Psychiatry ·Vivian W. L. Tsang, James S.H. Wong, Jean N. Westenberg, (unknown), (unknown), Mohammadali Nikoo, (unknown), (unknown), Pouya Azar, Kerry L. Jang, Michael Krausz	10
6	24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release 2024 ·Journal of Psychoactive Drugs ·Pouya Azar, (unknown), James S.H. Wong, Mohammadali Nikoo, (unknown), (unknown), Nickie Mathew, (unknown), Sarah E. Wakeman, (unknown), Michael Krausz, Julio Montaner, Anil R. Maharaj	2
7	Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder 2024 ·Addiction Science & Clinical Practice ·Pouya Azar, (unknown), (unknown), James S.H. Wong, (unknown), (unknown), (unknown), (unknown), Nickie Mathew, (unknown), Michael Krausz, Anil R. Maharaj	1
8	48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine 2023 ·Journal of Addiction Medicine ·Pouya Azar, James S.H. Wong, Nickie Mathew, (unknown), Nilufar Partovi, Michael Krausz, (unknown), (unknown), Marianne Harris, Rolando Barrios, Julio Montaner, Anil R. Maharaj	3
9	Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trial 2022 ·Addiction ·Mohammadali Nikoo, (unknown), (unknown), (unknown), (unknown), Fiona Choi, Marc Vogel, Ali Gholami, (unknown), James S.H. Wong, Ehsan Moazen‐Zadeh, (unknown), (unknown), Fatemeh Mohammadian, (unknown), Christian G. Schütz, Kerry L. Jang, Shahin Akhondzadeh, Michael Krausz	4
10	48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method 2022 ·Journal of Addiction Medicine ·Pouya Azar, James S.H. Wong, Nickie Mathew, Marc Vogel, Jeanmarie Perrone, Andrew A. Herring, Michael Krausz, Julio Montaner, Mark K. Greenwald, Anil R. Maharaj	5
11	Cost Analysis of Buprenorphine Extended-Release Injection Versus Sublingual Buprenorphine/Naloxone Tablets in a Correctional Setting 2022 ·Journal of Correctional Health Care ·James S.H. Wong, Sarah Masson, Alan Huang, (unknown), (unknown), Tony Porter, Nader Sharifi, Pouya Azar, Nickie Mathew	5
12	Case report: acute care management of severe opioid withdrawal with IV fentanyl 2022 ·Addiction Science & Clinical Practice ·Pouya Azar, Jean N. Westenberg, (unknown), James S.H. Wong, George Isac, Nickie Mathew, Michael Krausz	5
13	Developing A Rapid Transfer from Opioid Full Agonist to Buprenorphine: “Ultrarapid Micro-Dosing” Proof of Concept 2022 ·Journal of Psychoactive Drugs ·Pouya Azar, Nickie Mathew, (unknown), James S.H. Wong, Jean N. Westenberg, Christian G. Schütz, Mark K. Greenwald	7
14	Shifting North American drug markets and challenges for the system of care 2021 ·International Journal of Mental Health Systems ·Michael Krausz, Jean N. Westenberg, Nickie Mathew, G. Thomas Budd, James S.H. Wong, Vivian W. L. Tsang, Marc Vogel, (unknown), (unknown), Kerry L. Jang, Fiona Choi	16
15	Non-beverage alcohol consumption among individuals experiencing chronic homelessness in Edmonton, Canada: a cross-sectional study 2021 ·Harm Reduction Journal ·Jean N. Westenberg, Mostafa Kamel, (unknown), (unknown), James S.H. Wong, (unknown), Kerry L. Jang, Michael Krausz	8
16	Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial 2021 ·Addiction Science & Clinical Practice ·James S.H. Wong, Mohammadali Nikoo, Jean N. Westenberg, (unknown), (unknown), Michael Krausz, Christian G. Schütz, Marc Vogel, (unknown), Jessica Moe, Shane Arishenkoff, Donald Griesdale, Nickie Mathew, Pouya Azar	28
17	Impact of opioid agonist treatment on mental health in patients with opioid use disorder: a systematic review and network meta-analysis of randomized clinical trials 2021 ·The American Journal of Drug and Alcohol Abuse ·Ehsan Moazen‐Zadeh, (unknown), (unknown), Mostafa Kamel, James S.H. Wong, Amirhossein Modabbernia, Peter Blanken, Uwe Verthein, Christian G. Schütz, Kerry L. Jang, Shahin Akhondzadeh, Michael Krausz	19
18	A Case Report: Rapid Micro‐Induction of Buprenorphine/Naloxone to Administer Buprenorphine Extended‐Release in an Adolescent With Severe Opioid Use Disorder 2020 ·American Journal on Addictions ·Pouya Azar, James S.H. Wong, (unknown), Eva Moore, (unknown), Mohammadali Nikoo, Samantha Young	21
19	Understanding eHealth Cognitive Behavioral Therapy Targeting Substance Use: Realist Review 2020 ·Journal of Medical Internet Research ·(unknown), James S.H. Wong, Mohammadali Nikoo, (unknown), Ehsan Moazen‐Zadeh, (unknown), (unknown), Kerry L. Jang, Michael Krausz	16
20	HB A₂−Parkville or δ 47δ Chain Variant 1991 ·Hemoglobin ·(unknown), (unknown), (unknown), James S.H. Wong, W. G. Hughes, (unknown), (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact